Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Gilead Expands R&D In Canada
by Rick Mullin
November 19, 2012
| A version of this story appeared in
Volume 90, Issue 47
Gilead Sciences has agreed to purchase and develop a 10-acre plot in Edmonton, Alberta. The company plans to build a 45,000-sq-ft R&D facility on the site, which is across the street from its existing R&D operation in Edmonton. The new building will house at least 80 process chemistry and analytical development scientists. The company, which currently has a staff of 220 in Edmonton, plans to hire 50 new researchers. Gilead purchased its current Edmonton site from Degussa, now Evonik Industries, for $146 million in 2006.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X